Sunday, September 13, 2009

Regeneron halts Phase 3 trial of cancer drug - Albany Times Union


Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

No comments:

Post a Comment